ClinVar Miner

Submissions for variant NM_001353921.2(ARHGEF9):c.13A>G (p.Arg5Gly)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV003025239 SCV003345121 uncertain significance Developmental and epileptic encephalopathy, 8 2022-08-22 criteria provided, single submitter clinical testing The ARHGEF9 gene has multiple clinically relevant transcripts. This variant occurs in alternate transcript NM_001173479.1, and corresponds to NM_015185.2:c.-30821A>G in the primary transcript. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with ARHGEF9-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 5 of the ARHGEF9 protein (p.Arg5Gly).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.